| 1 |
Novak J, Julian BA, Mestecky J, et al. Glycosylation of IgA1 and pathogenesis of IgA nephropathy [J]. Semin Immunopathol, 2012,34(3):365-382.
|
| 2 |
Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy [J]. J Am Soc Nephrol,2011,22(10):1795-1803.
|
| 3 |
Mestecky J, Raska M, Julian BA, et al. IgA nephropathy:molecular mechanisms of the disease [J]. Annu Rev Pathol, 2013,8:217-240.
|
| 4 |
Wyatt RJ, Julian BA. IgA nephropathy [J]. N Engl J Med,2013,368(25):2402-2414.
|
| 5 |
Gharavi AG, Kiryluk K, Choi M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy [J]. Nat Genet,2011,43(4):321-327.
|
| 6 |
Yu XQ, Li M, Zhang H, et al. A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy [J]. Nat Genet,2012,44(2):178-182.
|
| 7 |
Rifai A, Small PA, Jr., Teague PO, et al. Experimental IgA nephropathy [J]. J Exp Med,1979,150(5):1161-1173.
|
| 8 |
Isaacs K,Miller F,Lane B. Experimental model for IgA nephropathy[J]. Clin Immunol Immunopathol,1981,20(3):419-426.
|
| 9 |
Isaacs KL, Miller F. Antigen size and charge in immune complex glomerulonephritis. Ⅱ. Passive induction of immune deposits with dextran-anti-dextran immune complexes [J]. Am J Pathol, 1983,111(3):298-306.
|
| 10 |
Emancipator SN, Gallo GR, Lamm ME. Experimental IgA nephropathy induced by oral immunization [J]. J Exp Med, 1983,157(2):572-582.
|
| 11 |
Iida H, Izumino K, Matsumoto M, et al. Glomerular deposition of IgA in experimental hepatic cirrhosis [J]. Acta Pathol Jpn, 1985,35(3):561-567.
|
| 12 |
Imai H,Nakamoto Y,Asakura K,et al. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis [J].Kidney Int,1985,27(5):756-761.
|
| 13 |
Tomino Y. IgA nephropathy:lessons from an animal model,the ddY mouse [J]. J Nephrol,2008,21(4):463-467.
|
| 14 |
Suzuki H, Suzuki Y, Yamanaka T, et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23 [J]. J Am Soc Nephrol,2005,16(5):1289-1299.
|
| 15 |
Imasawa T, Nagasawa R, Utsunomiya Y, et al. Bone marrow transplantation attenuates murine IgA nephropathy:role of a stem cell disorder [J]. Kidney Int,1999,56(5):1809-1817.
|
| 16 |
Suzuki H, Suzuki Y, Aizawa M, et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells [J]. Kidney Int,2007,72(3):319-327.
|
| 17 |
Okazaki K, Suzuki Y, Otsuji M, et al. Development of a model of early-onset IgA nephropathy[J]. J Am Soc Nephrol,2012,23(8):1364-1374.
|
| 18 |
Hiki Y,Kokubo T,Iwase H,et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy[J]. J Am Soc Nephrol,1999,10(4):760-769.
|
| 19 |
Zhang Z, Kundu GC, Zheng F, et al. Insight into the physiological function(s) of uteroglobin by gene-knockout and antisense-transgenic approaches [J]. Ann N Y Acad Sci,2000,923:210-233.
|
| 20 |
Zheng F, Kundu GC, Zhang Z, et al. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice [J]. Nat Med,1999,5(9):1018-1025.
|
| 21 |
Van Dixhoorn MG, Gorter A, Sato T, et al. Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1.1 antibody in the rat [J]. Kidney Int, 1996, 50(5):1612-1623.
|
| 22 |
Van Dixhoorn MG, Sato T, Muizert Y, et al. Combined administration of IgA and IgG anti-Thy-1 antibodies enhances renal inflammation in rats [J]. Kidney Int,1999,55(6):2299-2309.
|
| 23 |
Chen A, Ding SL, Sheu LF, et al. Experimental IgA nephropathy.Enhanced deposition of glomerular IgA immune complex in proteinuric states [J]. Lab Invest,1994,70(5):639-647.
|
| 24 |
Launay P, Grossetete B, Arcos-Fajardo M, et al. Fcalpha receptor(CD89) mediates the development of immunoglobulin A (IgA)nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice [J]. J Exp Med,2000,191(11):1999-2009.
|
| 25 |
Novak J. Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor [J]. J Am Soc Nephrol,2012,23(3):371-373.
|
| 26 |
Novak L, Moldoveanu Z, Huang ZQ, et al. Assessment of glomerular changes in a passive mouse model of IgA nephropathy[J]. J Am Soc Nephrol,2013,24:570A.
|
| 27 |
Sano T, Hiki Y, Kokubo T, et al. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli [J]. Nephrol Dial Transplant, 2002, 17(1):50-56.
|
| 28 |
Nishie T, Miyaishi O, Azuma H, et al. Development of immunoglobulin A nephropathy-like disease in beta-1, 4-galactosyltransferase-I-deficient mice [J]. Am J Pathol, 2007, 170(2):447-456.
|
| 29 |
Kakani S, Yardeni T, Poling J, et al. The Gne M712T mouse as a model for human glomerulopathy [J]. Am J Pathol,2012,180(4):1431-1440.
|
| 30 |
Berthelot L, Papista C, Maciel TT, et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors [J]. J Exp Med,2012,209(4):793-806.
|